Nephropathy in patients with recently diagnosed type 2 diabetes mellitus black Africans

East African Medical Journal

Volumn 79, Issue 8, 2002, Pages 399-404

  Wanjohi, F W ^a   Otieno, F C F ^b   Ogola, E N ^b   Amayo, E O ^b  

^a AGA KHAN UNIVERSITY   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH; HOSPITAL; HUMAN; HYPERTENSION; KENYA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLISM; MICROALBUMINURIA; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; OUTPATIENT; PREVALENCE; PROTEINURIA; RISK FACTOR; TIME;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALBUMINURIA; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, URBAN; HUMANS; HYPERTENSION; KENYA; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTORS; TIME FACTORS; URBAN HEALTH;

EID: 0036704511     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Parving, H.H., Tarrow, L. and Rossing, P. Genetics of diabetic nephropathy. J. Am. Soc. Neprol. 1996; 7:2509-2517.
2. Deckert, T., Parving, H.H. and Anderson, A.R. et al. Diabetic Nephropathy: A clinical and morphomeric study. In: Eschwege E. Ed. Advances in Diabetic Epidemiology. Amsterdam: Elsevier Biomedical press: 1982: 235-243.
3. Grefelle, A., Beweick M., Parsons V., Snowden S., Taube, D. and Watkins, P.J. NIDDM and renal replacement therapy. Diabetic Med. 1988; 5:172-176.
4. Parving, H.H., Gall, M.A., Skott, P. et al. Prevalence and cause of albuminuria in NIDDM patients. Kidney Int. 1992; 41: 758-762.
5. Morgensen, C.E., Schmitz, A. and Christensen, C.K. Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes Metabol. Rev. 1988; 4: 453-458.
6. Schimtz, A., Christensen, T. and Jensen, F.T. Glomerular filtration rate and kidney volume in normo-albuminuric non-insulin dependent diabetic patients - Lack of hyperfiltration and renal hypertrophy in uncomplicated NIDDM. Scand. J. Clin. Lab. Invest. 1989; 49:103-108.
7. Brenner, B.M., Garcia, D.L. and Anderson, S. Glomeruli and blood pressure: Less one. More other? Am. J. Hypertens. 1988: 1: 335-347.
8. Schmidt, K., Pesce, C., Liu, Q., Nelson, R.G., Bennet, P.H., Kamitschnig,H., Striker, L.J. and Striker, G.E. Large glomerular size in Pima Indians: Lack of change with diabetic nephropathy. J. Am. Soc. Nephrol. 1992; 3: 229-235.
9. Burton, C. and Harris, K.P.G. The role of proteinuria in the progression of chronic renal failure. Q. J. Med. 1988; 67: 343-354.
10. Amos, A.F., McCarty, D.J. and Zimmet, P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic Medicine. 1997; 14(suppl 5): S1-S85.
11. Erasmus, R.T., Blanco, Okesina, A.B. and Mesa, J. Hypertension, proteinuria and renal insufficiency in Black South Africans with NIDDM. Diabetes International. 1999; 9: 66-69.
12. Xavier, Pi-Sunyer F. Obesity. In: Bennet, J.C. and Plum, J.C. (eds). Cecil Textbook of Medicine. Philadelphia, W.B. Saunders Co. 1996, pp 1161-1167.
13. Bannister, K.M. and Field, M.F. Clinical physiology of the kidney: tests of renal function and structure. Oxford Textbook of Medicine. 3rd Ed. Weatherall, D.J., Ledingham, J.G.G. and Warrel, D.A. (eds). Oxford University Press. 1996; 3: 4016-4017.
14. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1998; 21(suppl 1): S23-S31.
15. Friedwald, W.T., Levy, R., Friendricksons, D.S. Estimation of LDL cholesterol in plasma without the use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
16. Parving, H.H., Gall, M.A., Skøtt, P., Jorgensen, H.E., Lokkegard, H., Jorgensen, F. et al. Prevalence and causes of albuminuria in non-insulin dependent diabetic patients. Kidney Int. 1992; 41: 758-762.
17. Torfritt, O., Agardh, E. and Agardh, C-D. Albuminuria and associated medical risk factors. A cross-sectional study in 451 type 2 diabetic patients. Part 2. J. Diab. Complicat. 1991; 5: 29-34.
18. Gall, M.A., Rossing, P., Skøtt, P., Damsbo, P., Vaag, A., Bech, K. et al. Prevalence of micro- and macro-albuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 diabetic patients. Diabetologia. 1999; 34:655-661.
19. Marshall, S.M. and Alberti, K.G.M.M. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin dependent diabetes. Q. J. Med. 1989; 70:61-71.
20. Keller, C.K., Bergis, K.H., Fliser, D. Ritz, E. Renal findings in short term Type 2 diabetes. Am. Soc. Nephrol. 1996; 7: 2627-2635.
21. Standl, E. and Stiegler, H. Microalbuminuria in a random cohort of recently diagnosed type 2 diabetic patients living in greater Munich area. Diaetologia. 1993; 36:1017-1020.
22. Anonymous. UK Prospective Diabetes study (UKPDS). Urinary albumin excretion over 3 years in diet-treated type 2 diabetic patients and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia. 1993; 36:1021-1029.
23. Chaiken, R.L., Khawaja, R., Bard, M., Eckert Norton, M., Benerji, M.A. and Lebowitz, H.E. Utility of untimed urinary albumin measurements in assessing albuminuiria in Black NIDDM subjects. Diabetes Care. 1997; 20:709-713.
24. Tarnow, L., Rossing, P., Gall, M.A., Nielsen, F.S. and Parving, H.H. Prevalence of arterial hypertension in diabetic patients before and after JNC-V. Diabetes Care. 1994. 17:1247-1251.
25. Nelson, R.G., Petit, D.J., Baird, H.R., Charles, M.A., Liu, Q.Z., Bennet, P.H. and Knowler, W.C. Pre-diabetic blood pressure predicts urinary albumin excretion after onset of type 2 (NIDDM) diabetes in Pima India. Diaetologia. 1993; 36:998-1001.
26. Rossing, P., Hommel, E., Schmidt, U.M. and Parving, H.H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes. 1993; 42: 715-719.
27. Viberti, G.C. and Earle, K. Predisposition to essential hypertension and the development of diabetic nephropathy. J. Am. Soc. Nephrol. 1992; 3(suppl):527-533.
28. Hasslacher, C., Wolfrum, M., Stech, G., Wahl, P. and Ritz, E. Diabetic nephropathy in type 2 diabetes: Effects of metabolic control and blood pressure on its development and course. Deustche Med. Wochenschrist. 1987; 112:1445-1449.
29. Ritz, E., Hassclacher, C., Mann, J.F. and Guo, J.Z. Hypertension and Vascular Disease as Complications in Diaebtes in Hypertension - Pathophysiology, Diagnosis and Management, edited by Laragh, H.H. and Brenner, B.M. New York, Raven Press. 1990, pp 1705.
30. Hypertension in Diabetes Study Group. Hypertension in Diabetes Study: I-Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J. Hypertension. 1993; 11:309-317.
31. Ballard, D.J., Humphrey, L.L., Melton, L.J. et al. Epidemiology of persistent proteinuria in type 2 diabetes mellitus. Population based study in Rochester, Minnesota. Diabetes. 1988; 37:405-412.
32. Haneda, M., Kikkawan, R., Togawa, M., Koyad, D., Kajiwara, N., Uzu, T. and Shigeta, Y. High blood pressure is a risk factor for develpoment of microalbuminuria in Japanese subjects with NIDDM. J. Diabetes Complications. 1992; 6:181-185.
33. UK Prospective Diabetic Study Group (UKPDS) IX: Relationships of urinary albumin and N-acetylglusosaminidase to glycaemia and hypertension at diagnosis of type 2 diabetes mellitus and after 3 months of diet therapy. Diaetologia. 1993; 36:835-842.
34. Gilbert, R.E., Tsalamandris, C., Bach, L.A. et al. Long-term glycaemic control and the rate of progression in early diabetic kidney disease. Kidney Int. 1993; 44:855-859.
35. Davis, M.E.T., Stratton, I.M., Fox, J.C. and Holmann, R.R. UKPDS 22. Effect of age at diagnosis on diabetic tissue damage during the fist six years of NIDDM. Diabetes Care. 1997; 20:1435-1441.
36. Sasaki, T., Kurata, H., Nomura, K., Utsunomi, Y.A.K. and Ikeda, Y. Amelioration of proteinuria with pravastatin in hypercholesterolaemic patients with diabetes mellitus. Jpn. J. Med. 1990; 29:156-163.
37. Yoshida, H., Kuriyama, S., Atsumi, Y., Tomonari, H., Mitarai, T., Hamaguchi, E., Kubo, H. et al. Angiotensin I converting enzyme gene polymorphism in NIDDM. Kidney Int. 1996; 567-664.
38. Rutherford, P.A., Thomas, T.H., Taylor, R. and Wilkinson, R. Nephropathy and changes in sodium-Lithium contertransport kinetics in type 2 diabetis mellitus. J. Hum. Hypertens. 1994; 8:29-35.
39. Fuller, J.H., Stevens, L.K., Wang, S.L. and the WHO Multinational study group. Risk factors for cardiolovascular mortality and morbidity. The WHO multinational study of vascular disease in diabetes. Diaetologia. 2001; 44(suppl 2):1017-1020.